# Nuclide record medicare-ced (term). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/terms/medicare-ced/>
  a schema:DefinedTerm ;
  nuclide:kind "term" ;
  schema:identifier "medicare-ced" ;
  schema:name "Medicare coverage with evidence development"@en ;
  schema:alternateName "coverage with evidence development"@en, "CED"@en, "national coverage determination"@en, "national coverage determinations"@en, "NCD 90.2"@en, "Medicare NGS coverage"@en, "Medicare coverage of cancer drugs"@en, "protected classes"@en ;
  schema:description "Medicare's way of paying for a promising but uncertain test or treatment only for patients enrolled in a registry or study, used for PET scans in cancer from 2006 and now the frame for how Medicare covers gene panels and cell therapies."@en ;
  schema:url <https://nuclide.cc/terms/medicare-ced/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.cms.gov/medicare/coverage/evidence>, <https://www.cms.gov/medicare-coverage-database/> ;
  nuclide:tag "law", "us" .